SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-21-000021
Filing Date
2021-04-05
Accepted
2021-04-05 07:22:31
Documents
16
Period of Report
2021-04-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20210405.htm   iXBRL 8-K 41035
2 EX-99.1 xlrn-20210405form8xkex991.htm EX-99.1 27818
8 image_02.jpg GRAPHIC 80392
  Complete submission text file 0001280600-21-000021.txt   337962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20210405.xsd EX-101.SCH 2457
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20210405_cal.xml EX-101.CAL 736
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20210405_def.xml EX-101.DEF 2941
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20210405_lab.xml EX-101.LAB 26331
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20210405_pre.xml EX-101.PRE 14322
9 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20210405_htm.xml XML 10770
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 21803724
SIC: 2836 Biological Products, (No Diagnostic Substances)